Related Experiment Video

Updated: May 13, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Therapeutic implications of targeting energy metabolism in breast cancer

Meena K Sakharkar1, Babita Shashni, Karun Sharma

  • 1Graduate School of Life and Environmental Sciences, University of Tsukuba, Tennoudai 1-1-1, Tsukuba 305-8572, Japan.

PPAR Research
|February 23, 2013
PubMed

Insights

Peroxisome proliferator-activated receptors (PPARs) regulate cellular energy. PPARγ agonists show potential in treating metabolic diseases and cancer, including breast cancer, by influencing energy metabolism.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Metabolism

Background:

  • Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors.
  • PPARγ agonists have shown potential in treating inflammation, diabetes, obesity, cancer, Alzheimer's disease (AD), and schizophrenia.
  • Cancer cells exhibit dysregulated glycolysis, suggesting metabolic interventions could be effective.

Purpose of the Study:

  • To discuss the function and role of PPARγ in energy metabolism.
  • To explore PPARγ's role in cancer biology.
  • To highlight PPARγ as a therapeutic target in breast cancer.

Main Methods:

  • Literature review and discussion of existing data on PPARγ.
  • Analysis of PPARγ's regulatory role in genes involved in metabolic pathways.
  • Examination of PPARγ's implications in cancer, particularly breast cancer.

Main Results:

  • PPARγ regulates genes crucial for cellular metabolic environment and energy generation.
  • Dysregulation of glycolysis in cancer cells suggests potential therapeutic avenues via metabolic modulation.
  • Synthetic PPARγ ligands have faced challenges due to limited understanding of their molecular basis and off-target effects.

Conclusions:

  • PPARγ plays a significant role in energy metabolism and cancer biology.
  • Understanding PPARγ's complex signaling is crucial for developing effective therapies.
  • PPARγ emerges as a promising therapeutic target for breast cancer treatment.

More Related Videos

Assessment of the Metabolic Profile of Primary Leukemia Cells06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...